Compare PRAX & SUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRAX | SUN |
|---|---|---|
| Founded | 2015 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 11.6B |
| IPO Year | 2020 | 2012 |
| Metric | PRAX | SUN |
|---|---|---|
| Price | $325.47 | $62.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 6 |
| Target Price | ★ $572.13 | $65.17 |
| AVG Volume (30 Days) | 364.5K | ★ 440.4K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.91% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $25,201,000,000.00 |
| Revenue This Year | N/A | $67.68 |
| Revenue Next Year | $6,395.88 | $17.10 |
| P/E Ratio | ★ N/A | $26.93 |
| Revenue Growth | N/A | ★ 11.05 |
| 52 Week Low | $26.70 | $47.98 |
| 52 Week High | $354.87 | $64.27 |
| Indicator | PRAX | SUN |
|---|---|---|
| Relative Strength Index (RSI) | 53.52 | 64.96 |
| Support Level | $290.36 | $51.81 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 18.34 | 1.84 |
| MACD | -2.56 | 0.08 |
| Stochastic Oscillator | 57.24 | 84.40 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states. The operating convenience stores are under the APlus, Stripes, Aloha Island Mart, and Tigermarket brands.